Peng Zhang, MD

Sichuan Cancer Hospital and Institute
Chengdu, Sichuan

Disclosures:

  • Employment: none
  • Compensation: none
  • Ownership: none
  • Leadership: none

Presentations

Sep 28

2929 - The 5-Year Follow-Up Results of the Efficacy and Safety of Pulse Low-Dose-Rate Radiotherapy (PLDR) Re-Irradiation in Recurrent Nasopharyngeal Carcinoma Patients, A Prospective, Open-Label,Multicenter, Phase II Clinical Trial
03:00pm - 04:00pm ET
Sep 29

1192 - Longitudinal Trajectories, Quality Of Life Impact, and Intervention Thresholds of Radiation-Induced Adverse Events in Head And Neck Cancer: An ePRO-Based Cohort Study
05:45pm - 05:50pm ET